Barr Pharmaceuticals, Inc.
(NYSE:BRL)|
64.29 0.00 (0.00%) Nov 19 - Close |
|
|
|
Pre-Market 65.59 +1.30 (2.02%) Wed, 19 Nov 2008 6:50 PM
- Compare BRL with:
- View: Line | Candlestick
Company Profile
Barr Pharmaceuticals, Inc.
225 Summit Ave
Montvale, NJ 07645-1523
United States - Map
Phone: (201) 930-3300
Fax: (201) 930-3330
Website: www.barrlabs.com
State of incorporation: Delaware
CEO: Bruce L. Downey
Employees: 8,900
Sector: Healthcare
Industry Group: Drugs
Industry: Drugs - Generic
Makes perscription drugs
A specialty pharmaceutical company, which is engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals.
Recent news for BRL
-
Israel Stocks: Market lower; Teva settles patent case, wins a round in another
MarketWatch - 23 hours ago
-
[$$] Sanofi-Aventis Settles Allegra Patent Suits
The Wall Street Journal Online - Yesterday at 9:01 ET
-
Sanofi-Aventis settles patent infringement cases
AP - Yesterday at 8:56 ET
-
Perrigo Acknowledges Settlement of NASACORT(R) AQ Nasal Spray Patent Litigation
PR Newswire - Yesterday at 8:00 ET
-
Teva, Barr settle patent dispute with Sanofi
AP - Yesterday at 7:26 ET
-
What Are Some of the Best Hedge Fund Managers Doing?
Seeking Alpha - Yesterday at 6:04 ET
-
UPDATE - Sanofi allows Allegra, Nasacort copies in U.S.
Reuters - Yesterday at 4:58 ET
-
Teva, Barr, Sanofi, Albany Molecular settle patent disputes
MarketWatch - Yesterday at 2:50 ET
-
Sanofi settles on Allegra, Nasacort generics in U.S.
Reuters - Yesterday at 2:13 ET
-
Barr Announces Agreements on Nasacort(R) AQ, Allegra(R) D-12 and Allegra(R) Patent Challenges
PR Newswire - Yesterday at 1:30 ET
Top members owning BRL
-
Top 51%
-37.57%3m:
-37.57%YTD:
-
Top 34%
-27.81%3m:
-27.81%YTD:
-
Top 37%
-30.03%3m:
-30.03%YTD: